Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayda Gursel

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Extracellular Vesicles|March 23, 2017
Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severityTamer Kahraman, Gozde Gucluler, Ismail Simsek, et al.
Frontiers in Medicine|September 27, 2024
Diagnostic challenges in cutaneous leishmaniasis due to atypical <i>Leishmania infantum</i>: pathologists' insights from re-emergence zonesSuheyla Ekemen, Muhammed Nalcaci, Seray Toz, et al.
Frontiers in Immunology|November 21, 2022
Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemiaIsmail Cem Yilmaz, Emre Dunuroglu, Ihsan Cihan Ayanoglu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2020
Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor CellsEsin Alpdundar Bulut, Banu Bayyurt Kocabas, Volkan Yazar, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2026
Circulating Extracellular Vesicles Drive Innate Immune Dysregulation in MIS-CTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
Journal of Clinical Immunology|January 21, 2021
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and TransplantationBasak Kayaoglu, Nurhan Kasap, Naz Surucu Yilmaz, et al.
Frontiers in Immunology|March 27, 2024
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activationBurcu Temizoz, Takayuki Shibahara, Kou Hioki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesiclesTamer Kahraman, Gozde Gucluler Akpinar, Muzaffer Yildirim, et al.
Vaccine|February 1, 2025
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccineIsmail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, et al.
Eclinicalmedicine|August 9, 2021
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemicPeter J Hotez, Carolina Batista, Yanis Ben Amor, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Extracellular Vesicles|March 23, 2017
Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severityTamer Kahraman, Gozde Gucluler, Ismail Simsek, et al.
Frontiers in Medicine|September 27, 2024
Diagnostic challenges in cutaneous leishmaniasis due to atypical <i>Leishmania infantum</i>: pathologists' insights from re-emergence zonesSuheyla Ekemen, Muhammed Nalcaci, Seray Toz, et al.
Frontiers in Immunology|November 21, 2022
Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemiaIsmail Cem Yilmaz, Emre Dunuroglu, Ihsan Cihan Ayanoglu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2020
Human Gut Commensal Membrane Vesicles Modulate Inflammation by Generating M2-like Macrophages and Myeloid-Derived Suppressor CellsEsin Alpdundar Bulut, Banu Bayyurt Kocabas, Volkan Yazar, et al.
The Journal of Allergy and Clinical Immunology|May 19, 2026
Circulating Extracellular Vesicles Drive Innate Immune Dysregulation in MIS-CTugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, et al.
Journal of Clinical Immunology|January 21, 2021
Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and TransplantationBasak Kayaoglu, Nurhan Kasap, Naz Surucu Yilmaz, et al.
Frontiers in Immunology|March 27, 2024
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activationBurcu Temizoz, Takayuki Shibahara, Kou Hioki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 17, 2024
Enhancing preventive and therapeutic cancer vaccine efficacy through biotherapeutic ligand-associated extracellular vesiclesTamer Kahraman, Gozde Gucluler Akpinar, Muzaffer Yildirim, et al.
Vaccine|February 1, 2025
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccineIsmail Cem Yilmaz, Emre Mert Ipekoglu, Berfu Saraydar Golcuklu, et al.
Eclinicalmedicine|August 9, 2021
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemicPeter J Hotez, Carolina Batista, Yanis Ben Amor, et al.
Pageof 5